» Articles » PMID: 3360056

Microelectrode Studies on the Acid Microenvironment Beneath Adherent Macrophages and Osteoclasts

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 1988 Apr 1
PMID 3360056
Citations 206
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoclasts and activated macrophages in culture were shown to generate an acidic microenvironment specifically in the attachment zone between the cell and the base of the culture dish. Measurements using pH microelectrodes revealed that osteoclasts, when firmly attached, could achieve a pH fall of about 1 unit min-1 to a limit value of pH 3.0 or less. Activated macrophages produced a slower fall of 0.5-2 pH units h-1 and a limit value of pH 3.6-3.7 was generally detected. The method of activation was relatively unimportant, but where macrophages formed clumps the pH effect was reinforced. Osteoclasts were also examined in situ in osteoporotic bone fragments in rabbit ear chambers, using a combination H+ and Ca2+ double-barrelled electrode. The pH readings reached a lower limit of 4.7 and the calcium concentration rose to a maximum of 40 mM in the erosion sites. In vivo such acid conditions would favor the direct extracellular action of secreted lysosomal proteinases in the degradation of collagen by both cell types.

Citing Articles

Long-Term Stability and Osteogenic Activity of Recycled Polysulfone-Calcium Silicate Bone Implants In Vitro.

Chang C, Huang Y, Ding S J Funct Biomater. 2025; 16(1).

PMID: 39852587 PMC: 11765742. DOI: 10.3390/jfb16010031.


Repurposing the prostaglandin analogue treprostinil and the calcium-sensing receptor modulator cinacalcet to revive cord blood as an alternate source of hematopoietic stem and progenitor cells for transplantation.

Prchal-Murphy M, Zehenter J, Fischer M, Pirabe A, Themanns M, Afrashteh B Front Pharmacol. 2025; 15():1444311.

PMID: 39850556 PMC: 11755040. DOI: 10.3389/fphar.2024.1444311.


Deletion of FNDC5/irisin modifies murine osteocyte function in a sex-specific manner.

Shimonty A, Pin F, Prideaux M, Peng G, Huot J, Kim H Elife. 2024; 12.

PMID: 38661340 PMC: 11045224. DOI: 10.7554/eLife.92263.


TGF-β signaling in health, disease, and therapeutics.

Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C Signal Transduct Target Ther. 2024; 9(1):61.

PMID: 38514615 PMC: 10958066. DOI: 10.1038/s41392-024-01764-w.


Engineering small-molecule and protein drugs for targeting bone tumors.

Wang Y, Wang C, Xia M, Tian Z, Zhou J, Berger J Mol Ther. 2024; 32(5):1219-1237.

PMID: 38449313 PMC: 11081876. DOI: 10.1016/j.ymthe.2024.03.001.